SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Saved in:
Bibliographic Details
Title: SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Authors: Pai SI; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA. sara.pai@mgh.harvard.edu., Cohen EEW; UC San Diego Health System, Moores Cancer Center, La Jolla, CA, USA., Lin D; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA.; Massachusetts Eye and Ear, Boston, MA, USA., Fountzilas G; Aristotle University of Thessaloniki, Thessaloniki, Greece., Kim ES; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Mehlhorn H; Universitaetsklinikum Leipzig, Klinik und Poliklinik fur HNO-Heilkunde, Leipzig, Germany., Baste N; Department of Oncology, Hospital Universitari Vall d'Hebron & Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Clayburgh D; Oregon Health & Science University, Portland, OR, USA., Lipworth L; Vanderbilt University Medical Center, Nashville, TN, USA., Resteghini C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Shara N; MedStar Health Research Institute, Hyattsville, MD, USA., Fujii T; Osaka International Cancer Institute, Osaka, Japan., Zhang J; Baylor College of Medicine, Houston, TX, USA., Stokes M; Evidera, Lexington, MA, USA., Wang H; AstraZeneca, Gaithersburg, MD, USA., Twumasi-Ankrah P; AstraZeneca, Gaithersburg, MD, USA., Wildsmith S; AstraZeneca, Cambridge, UK., Khaliq A; AstraZeneca, Gaithersburg, MD, USA., Melillo G; AstraZeneca, Gaithersburg, MD, USA., Shire N; AstraZeneca, Gaithersburg, MD, USA.
Source: Journal of translational medicine [J Transl Med] 2019 Dec 26; Vol. 17 (1), pp. 429. Date of Electronic Publication: 2019 Dec 26.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1479-5876
DOI:10.1186/s12967-019-02182-1